COVID-19 pandemic in Manipur
Overview of the COVID-19 pandemic in Manipur
The COVID-19 pandemic in Manipur is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case in the Indian state of Manipur was reported on 24 March 2020.
Background[edit]
The COVID-19 pandemic was confirmed to have reached India on 30 January 2020, originating from China. The first case in Manipur was a student who had returned from the United Kingdom.
Timeline[edit]
2020[edit]
On 24 March 2020, Manipur reported its first COVID-19 case. The patient was a 23-year-old woman who had returned from the UK. The state government quickly implemented measures to contain the spread, including lockdowns and travel restrictions.
In April 2020, the state reported its second case, a 65-year-old man who had attended a religious congregation in Delhi. This led to increased testing and contact tracing efforts.
2021[edit]

In 2021, the state faced challenges with the second wave of COVID-19, which saw a significant increase in cases and fatalities. The government ramped up vaccination efforts and imposed stricter lockdown measures to curb the spread.
Government Response[edit]
The government of Manipur implemented several measures to control the pandemic, including:
- Lockdowns and Curfews: Periodic lockdowns and curfews were imposed to limit movement and gatherings.
- Testing and Quarantine: Extensive testing and mandatory quarantine for travelers were enforced.
- Vaccination Campaigns: The state launched vaccination drives to immunize the population against COVID-19.
Impact[edit]
The pandemic had a significant impact on the economy and daily life in Manipur. Educational institutions were closed, and many businesses faced disruptions. The healthcare system was strained, but efforts were made to increase capacity and resources.
Related pages[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian